Helge Täubert

47.2k total citations · 1 hit paper
247 papers, 7.1k citations indexed

About

Helge Täubert is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Helge Täubert has authored 247 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Molecular Biology, 88 papers in Oncology and 80 papers in Cancer Research. Recurrent topics in Helge Täubert's work include Sarcoma Diagnosis and Treatment (48 papers), Cancer-related Molecular Pathways (45 papers) and Bladder and Urothelial Cancer Treatments (30 papers). Helge Täubert is often cited by papers focused on Sarcoma Diagnosis and Treatment (48 papers), Cancer-related Molecular Pathways (45 papers) and Bladder and Urothelial Cancer Treatments (30 papers). Helge Täubert collaborates with scholars based in Germany, United States and United Kingdom. Helge Täubert's co-authors include Peter Würl, Frank Bartel, Matthias Bache, Axel Meye, Matthias Kappler, Thomas Greither, Sven Wach, Hannelore Schmidt, Bernd Wullich and Gareth L. Bond and has published in prestigious journals such as Cell, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Helge Täubert

241 papers receiving 7.0k citations

Hit Papers

A Single Nucleotide Polymorphism in the MDM2 Promoter Att... 2004 2026 2011 2018 2004 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helge Täubert Germany 42 4.3k 2.9k 2.3k 1.3k 718 247 7.1k
Adrian Merlo Switzerland 46 5.8k 1.4× 2.8k 1.0× 1.9k 0.8× 1.1k 0.8× 758 1.1× 89 9.4k
Jun Yokota Japan 51 4.6k 1.1× 3.3k 1.2× 2.0k 0.8× 1.2k 0.9× 586 0.8× 140 8.3k
Stefano Indraccolo Italy 47 3.5k 0.8× 2.5k 0.9× 2.2k 0.9× 828 0.6× 501 0.7× 209 7.0k
Shafaat A. Rabbani Canada 50 3.9k 0.9× 2.5k 0.9× 2.2k 0.9× 1.1k 0.9× 227 0.3× 136 6.7k
Marie‐Pierre Chenard France 38 2.7k 0.6× 2.8k 1.0× 2.5k 1.1× 825 0.6× 1.3k 1.8× 137 6.9k
Chung‐Ji Liu Taiwan 45 4.5k 1.0× 1.9k 0.7× 3.5k 1.5× 555 0.4× 452 0.6× 159 6.9k
Tomoo Iwakuma United States 32 3.7k 0.8× 2.6k 0.9× 1.3k 0.6× 600 0.5× 223 0.3× 86 5.3k
Karin Milde‐Langosch Germany 42 3.2k 0.8× 1.9k 0.7× 1.8k 0.8× 551 0.4× 487 0.7× 130 5.6k
Maria Flavia Di Renzo Italy 40 4.0k 0.9× 1.9k 0.7× 995 0.4× 959 0.7× 1.3k 1.9× 106 7.4k
Jonathan D. Oliner United States 21 4.2k 1.0× 3.3k 1.2× 1.1k 0.5× 687 0.5× 236 0.3× 28 6.0k

Countries citing papers authored by Helge Täubert

Since Specialization
Citations

This map shows the geographic impact of Helge Täubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helge Täubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helge Täubert more than expected).

Fields of papers citing papers by Helge Täubert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helge Täubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helge Täubert. The network helps show where Helge Täubert may publish in the future.

Co-authorship network of co-authors of Helge Täubert

This figure shows the co-authorship network connecting the top 25 collaborators of Helge Täubert. A scholar is included among the top collaborators of Helge Täubert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helge Täubert. Helge Täubert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kalogirou, Charis, Helge Täubert, Sven Wach, et al.. (2024). Preoperative geriatric assessment to predict functional outcome after major urologic operations: Results from a multicenter study. European Journal of Surgical Oncology. 50(12). 108693–108693.
2.
Eckstein, Markus, Rudolf Jung, Verena Lieb, et al.. (2024). Prognostic and Predictive Potential of CCL5 Expression in Muscle-Invasive Bladder Cancer Patients. International Journal of Molecular Sciences. 25(12). 6325–6325. 3 indexed citations
3.
Marcou, Marios, Matthias Galiano, Anja Tzschoppe, et al.. (2023). Risk Factor Analysis for Long-Term Graft Survival Following Pediatric Kidney Transplantation: The Importance of Pretransplantation Time on Dialysis and Donor/Recipient Age Difference. Journal of Clinical Medicine. 12(22). 7014–7014. 3 indexed citations
4.
Lieb, Verena, Siegfried Hauch, Michael Gombert, et al.. (2022). Cell-Free DNA Sequencing Reveals Gene Variants in DNA Damage Repair Genes Associated with Prognosis of Prostate Cancer Patients. Cells. 11(22). 3618–3618. 1 indexed citations
5.
Serrero, Ginette, Binbin Yue, Robert Stöhr, et al.. (2022). Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients. Life. 12(5). 732–732. 1 indexed citations
6.
Eckstein, Markus, Verena Lieb, Rudolf Jung, et al.. (2021). Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients. Cells. 10(7). 1796–1796. 3 indexed citations
7.
Lieb, Verena, Siegfried Hauch, Michael Gombert, et al.. (2021). Cell-Free DNA Variant Sequencing Using Plasma and AR-V7 Testing of Circulating Tumor Cells in Prostate Cancer Patients. Cells. 10(11). 3223–3223. 3 indexed citations
8.
König, Paul, Markus Eckstein, Rudolf Jung, et al.. (2020). Expression of AR-V7 (Androgen Receptor Variant 7) Protein in Granular Cytoplasmic Structures Is an Independent Prognostic Factor in Prostate Cancer Patients. Cancers. 12(9). 2639–2639. 5 indexed citations
9.
Eckert, Alexander W., Daniel Bethmann, Johanna Kotrba, et al.. (2019). Investigation of the Prognostic Role of Carbonic Anhydrase 9 (CAIX) of the Cellular mRNA/Protein Level or Soluble CAIX Protein in Patients with Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences. 20(2). 375–375. 20 indexed citations
10.
Eckstein, Markus, Rudolf Jung, Ginette Serrero, et al.. (2019). Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer Patients. Cancers. 11(12). 2029–2029. 9 indexed citations
11.
Hart, Martin, Elke Nolte, Sven Wach, et al.. (2013). Comparative microRNA Profiling of Prostate Carcinomas with Increasing Tumor Stage by Deep Sequencing. Molecular Cancer Research. 12(2). 250–263. 74 indexed citations
12.
Lenos, Kristiaan, Anna M. Grawenda, Kirsten Lodder, et al.. (2012). Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer. Cancer Research. 72(16). 4074–4084. 51 indexed citations
13.
Yee, Karen S., Lukasz F. Grochola, Garth Hamilton, et al.. (2012). A RASSF1A Polymorphism Restricts p53/p73 Activation and Associates with Poor Survival and Accelerated Age of Onset of Soft Tissue Sarcoma. Cancer Research. 72(9). 2206–2217. 32 indexed citations
14.
Greither, Thomas, Franziska Koser, Matthias Kappler, et al.. (2012). Expression of human Piwi-likegenes is associated with prognosis for soft tissue sarcoma patients. BMC Cancer. 12(1). 272–272. 20 indexed citations
15.
Vázquez, Alexei, Lukasz F. Grochola, Elisabeth E. Bond, et al.. (2009). Chemosensitivity Profiles Identify Polymorphisms in the p53 Network Genes 14-3-3τ and CD44 That Affect Sarcoma Incidence and Survival. Cancer Research. 70(1). 172–180. 43 indexed citations
16.
Grochola, Lukasz F., Alexei Vázquez, Elisabeth E. Bond, et al.. (2009). Recent Natural Selection Identifies a Genetic Variant in a Regulatory Subunit of Protein Phosphatase 2A that Associates with Altered Cancer Risk and Survival. Clinical Cancer Research. 15(19). 6301–6308. 20 indexed citations
17.
Täubert, Helge, et al.. (2008). Predicting MACE breeding values on a phantom country scale. Bulletin - International Bull Evaluation Service/Interbull bulletin. 152.
18.
König, S., Helge Täubert, Henner Simianer, & H.H. Swalve. (2002). The Interbull audit project part I - Results of an international survey. Bulletin - International Bull Evaluation Service/Interbull bulletin. 161. 1 indexed citations
19.
Täubert, Helge, H. Brandt, & P. Glodek. (1999). ESTIMATION OF GENETIC PARAMETERS FOR FARROWING TRAITS IN PUREBRED AND CROSSBRED SOWS AND ESTIMATION OF THEIR GENETIC RELATIONSHIPS. 53(3). 205–209. 2 indexed citations
20.
Würl, Peter, Helge Täubert, Matthias Bache, et al.. (1996). Frequent occurrence of p53 mutations in rhabdomyosarcoma and leiomyosarcoma, but not in fibrosarcoma and malignant neural tumors. International Journal of Cancer. 69(4). 317–323. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026